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S U M M A R Y
Objectives: Glomerulonephritis is an important extrahepatic manifestation of hepatitis B virus (HBV) and
hepatitis C virus (HCV) infection. HBV and HCV infection may be occult, and they are often overlooked by
both patients and doctors. The aim of this study was to assess the importance of HBV and HCV infection
in glomerulonephritis patients with undetectable HBV surface antigen (HBsAg) and HCV antibody in
serum.
Methods: The HBsAg, the HBV core antigen (HBcAg), and the HCV antigen were detected using
immunohistochemistry in frozen renal tissues of 500 glomerulonephritis patients without serological
evidence of HBV and HCV infection. Electron microscopy was used to trace the virus particles, and
clinicopathological features were also reviewed.
Results: HBsAg or HBcAg was positive in nine out of 500 cases (9/500, 1.8%). Three cases were HBsAg-
positive and another six cases were HBcAg-positive. The HCV antigen was found in eight cases (8/500,
1.6%). There was one case of HBV and HCV co-infection (1/500, 0.2%). Under electron microscopy, virus
particles were found in the base membrane and cytoplasm of endotheliocytes in the glomerulus. The
most common clinical manifestation was nephrotic syndrome (9/18), followed by nephritic syndrome
(7/18). Membranous nephropathy was the most common pathological diagnosis (5/18), followed by
mesangioproliferative glomerulonephritis (4/18) and IgA nephropathy (4/18).
Conclusions: Occult HBV and HCV infection might be implicated in HBV- or HCV-associated
glomerulonephritis. More attention should be focused on the underlying cause.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections
are severe public health problems. They have been associated with
numerous diseases, such as chronic liver disease and hepatocellu-
lar carcinoma (HCC). Glomerulonephritis is an important extrahe-
patic manifestation of HBV and HCV infection. Various viral
antigens and viral nucleic acids have been observed in the
glomeruli of some patients with glomerulonephritis.1,2 It has been
reported that the hepatitis virus can cause kidney lesions through
immune complex deposition.3,4 The diagnosis of HBV- or HCV-
associated glomerulonephritis is made by the ﬁndings of positive
serum viral markers and the immunohistochemical demonstration
of viral antigens in a kidney biopsy specimen.5–7* Corresponding author. Tel./Fax: +86 451 86669472.
** Co-corresponding author.
E-mail addresses: Jinxm55@yahoo.com.cn (X. Jin), Dr-louge@163.com (G. Lou).
1 They both contributed equally to this work.
1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.01.017At our institution, the HBV surface antigen (HBsAg) and core
antigen (HBcAg) have conventionally been detected using immu-
nohistochemistry on frozen renal tissues of patients with HBV
infection by serological test. The diagnosis of HBV-related
glomerulonephritis is important for guiding clinical treatment.
The HCV antigen is not detected due to the low infection rate of
HCV in patients having a renal biopsy. In fact, HBV and HCV
infections are sometimes occult. These patients are characterized
by the presence of HBV or HCV infection with undetectable HBsAg
and HCV antibody in serum, whereas the viral DNA or RNA may be
present in the blood or tissues, or the tissues may be positive for
viral antigens.8–10 Occult HBV and HCV infections have often been
neglected. However, they can also cause immune complex
deposition in tissues. Hence an occult HBV or HCV infection might
also cause HBV- or HCV-associated glomerulonephritis.
In this study, we detected HBsAg, HBcAg, and the HCV antigen
in the renal tissues of patients who were seronegative for HBV and
HCV infection. The results might provide physicians with a clue to
identifying the underlying etiology of glomerulonephritis.ses. Published by Elsevier Ltd. All rights reserved.
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2.1. Patients
This study included 500 consecutive patients who underwent
renal biopsies at Harbin Medical University from March 1, 2011 to
October 31, 2011. Two hundred and twenty-seven cases were male
and 273 were female. Patient age ranged from 5 to 84 years. All renal
tissues were obtained by percutaneous needle biopsy, and the
specimens were processed by light, immunoﬂuorescence (IF), and
electron microscopy to obtain a pathological diagnosis. All cases met
the following criteria: (1) diagnosed with glomerulonephritis; (2)
seronegative for HBV and HCV infection (the baseline hepatitis
serology proﬁles are provided in Table 1); (3) at least three frozen
sections remained after diagnosis; and (4) all cases had complete
clinical records. The research was carried out in accordance with the
principles of the Declaration of Helsinki. All patients gave their
informed consent prior to inclusion in the study. The ethics committee
of Harbin Medical University speciﬁcally approved this study.
2.2. Immunohistochemistry
Immunohistochemistry staining was performed on frozen renal
tissue sections. The following primary antibodies were used: anti-
HBsAg, anti-HBcAg, and anti-HCV antigen (ZSGB Bio, Beijing,
China). The antibodies were diluted to 1:50, and the sections were
incubated in the antibodies at 4 8C overnight. The streptavidin–
peroxidase kit was used as a secondary antibody (ZSGB Bio, Beijing,
China). Staining was visualized using 3,30-diaminobenzidine (DAB;
ZSGB Bio, Beijing, China). Brown granules in the glomeruli were
regarded as positive, and expression in the renal tubules was
excluded in this study. The result was scored according to the
intensity and area of staining as follows: (1) intensity: 0 if negative,
1 if pale brown, 2 if brown, 3 if dark brown; (2) positive area of all
the glomeruli: 0 if <5%, 1 if 6–25%, 2 if 26–50%, 3 if >50%; (3) total
scores = (1)  (2): ‘’ if 0, ‘+’ if 1–2, ‘++’ if 3–4, ‘+++’ if >5. Renal
tissues from non-HBV- and non-HCV-infected patients were used
as the negative controls.
2.3. Electron microscopy
To trace the virus particles in the renal tissue, 70–80 nm
sections were cut from the tissue blocks that were embedded inTable 1
Serological and immunohistochemical test for HBV and HCV
Case Serological test 
HBsAg HBsAb HBeAg HBeAb 
1     
2     
3     
4     
5     
6     
7  +   
8     
9     
10  +   
11  +   
12     
13     
14  +   
15     
16  +   
17     
18     
HBsAg, hepatitis B surface antigen; HBsAb, hepatitis B surface antibody; HBeAg, hepatitis 
hepatitis C virus antibody; HBcAg, hepatitis B core antigen; HCVAg, hepatitis C virus aEpon 812. The sections were then stained with uranyl acetate and
lead citrate and viewed again on a JEM 1220 transmission electron
microscope (JEOL, Tokyo, Japan).
2.4. Clinical data
The clinical data were reviewed in patients with viral antigens
in renal tissue according to immunohistochemical assay, including
age, gender, degree of hematuria (scored between 0 and 4
according to the number of red cells per high-power ﬁeld in
sediment as follows: 0 if 0–5, 1 if 6–20, 2 if 21–50, 3 if 51–100, and
4 if >100), proteinuria, hypertension (systolic blood pressure/
diastolic blood pressure 140/90 mmHg for adults, 130/
90 mmHg for school age children), and blood urea nitrogen
(normal values 2.9–8.2 mmol/l).11 The estimated glomerular
ﬁltration rate (eGFR) was calculated using the modiﬁed MDRD
(Modiﬁcation of Diet in Renal Disease) equation for adults and the
Schwartz formula for children.12,13 Meanwhile, renal function was
staged as chronic kidney disease (CKD) I–V according to the
standard American stages of renal function based on GFR: I, normal
or increased GFR with renal damage (GFR >90 ml/min/1.73 m2); II,
mildly decreased GFR with renal damage (GFR 60–89 ml/min/
1.73 m2); III, moderately decreased GFR (GFR 30–59 ml/min/
1.73 m2); IV, severely decreased GFR (GFR 15–29 ml/min/
1.73 m2); and V, kidney failure (GFR <15 ml/min/1.73 m2 or
dialysis).14
3. Results
3.1. Detection of viral antigens in renal tissues of patients with
glomerulonephritis
The results of the immunohistochemical staining are shown in
Table 1. Nine out of 500 cases (1.8%) were positive for HBsAg or
HBcAg. Three cases were HBsAg-positive and another six cases
were HBcAg-positive. HCV antigen tests were positive in eight
cases (1.6%). Furthermore, one case had HBV and HCV co-infection
(0.2%). The positive glomeruli were brown (Figure 1a).
In the renal tissues with HBV or HCV antigens, the virus
particles were observed by electron microscopy in the base
membrane and cytoplasm of endotheliocytes in the glomerulus
(Figure 1b), which provided evidence for viral infection.Immunohistochemistry test
HBcAb HCVAb HBsAg HBcAg HCVAg
  +  
   ++ +
   + 
   ++ 
  ++  
  ++  
   +++ 
   + 
   + 
   ++ 
    +
    +
    ++
    +
    +
    +
    ++
    +
B e antigen; HBeAb, hepatitis B e antibody; HBcAb, hepatitis B core antibody; HCVAb,
ntigen.
Figure 1. Detection of viral antigens and particles in renal tissues. (a)
Immunohistochemical staining of frozen sections. HBsAg, HBcAg, and HCV
antigens located in the glomerulus; positive staining in the glomerulus is
brown. (b) Electron microscopy. The virus particles can be found in the base
membrane of the glomerulus.
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renal tissues
In all patients with infection, the most common clinical
manifestation was nephrotic syndrome (9/18), followed by
nephritic syndrome (7/18). Membranous nephropathy was the
most common pathological diagnosis (5/18), followed by mesan-
gioproliferative glomerulonephritis (4/18) and IgA nephropathy
(4/18). The mean proteinuria was 4.9  3.6 g/day, and the level ofTable 2
Clinicopathological features of patients positive for HBV and HCV antigens
HBV 
HBsAg (n = 3) HBcAg 
Clinical parameters
Age, years (mean  SD) 28.7  13.5 39.3  2
Gender (M/F) 2/1 0/6 
Hematuria 1.3  1.5 1.3  1.
Proteinuria (g/day) 5.0  3.9 3.6  3.
Hypertension 1 2 
Blood urea nitrogen (>8.2 mmol/l) 0 1 
Clinical manifestation
Asymptomatic hematuria 0 1 
Nephritic syndrome 1 3 
Nephrotic syndrome 2 2 
Pathological diagnosis
Membranous nephropathy 0 3 
Mesangioproliferative glomerulonephritis 1 1 
IgA nephropathy 0 2 
Minimal change glomerulopathy 1 0 
Glomerular minor lesion 1 0 
Henoch–Scho¨nlein purpura nephritis 0 0 
CKD stages
I 2 4 
II 1 1 
III 0 1 
IV 0 0 
V 0 0 
CKD, chronic kidney disease; F, female; HBV, hepatitis B virus; HBcAg, hepatitis B core
standard deviation.proteinuria was relatively higher. Most patients with HBV and HCV
antigens showed mild injury, classiﬁed as CKD I–II (13/18). Although
there were more patients with CKD III–V in the HCV group than in the
HBV group, the difference was not statistically signiﬁcant (p > 0.05).
The clinical parameters showed no signiﬁcant difference between
HBsAg, HBcAg, and HCV antigen positive groups (p > 0.05). The
relationship between hepatitis virus infection and clinicopathological
features is shown in Table 2.
4. Discussion
Although the incidence of new infection is decreasing with the
increasing practice of hepatitis B vaccination, China is still an area
highly endemic for HBV infection. The estimated national
prevalence in 2006 was 7.2% according to the nationwide
seroepidemiologic survey for HBV.15 However, current HCV
epidemiology in China is largely uncertain, and no population-
based prevalence rate is available.16,17
HBV and HCV infections have been shown to cause several
extrahepatic lesions through deposition of immune complexes in
different organs, including HBV- and HCV-associated glomerulo-
nephritis.18,19 Most studies explain the relationship between
hepatitis viruses and glomerulonephritis by the detection of
antigens or viral nucleic acids in the renal tissues of infected
patients with glomerulonephritis.20–22 Lai et al. examined parafﬁn
sections of kidney biopsies from 40 chronic HBsAg carriers with
glomerulonephritis, and glomerular HBV antigens were present in
all biopsies by immunoﬂuorescence; however the detection rate of
HBV DNA and RNA was relatively lower.21 Almost all morphologi-
cal forms of renal disease can be found in these patients and
membranous nephropathy is the most common.3 It has been
reported that antiviral therapy can signiﬁcantly improve the
symptoms and inhibit the progression of HBV- or HCV-associated
glomerulonephritis.5,23
Although the deﬁnition of occult HBV infection is controversial
and its clinical signiﬁcance remains unclear, more and more data
suggest its important role in various diseases.9,24 Occult HBV or HCV
infection might also have an association with glomerulonephritis.HCV (n = 8) Co-infection (n = 1) Total (n = 18)
(n = 6)
1.5 35.3  13.4 20 35.5  16.1
4/4 1/0 7/11
0 1.6  1.6 4 1.6  1.4
8 5.9  3.7 7.0 4.9  3.6
1 0 4
1 0 2
1 0 2
3 0 7
4 1 9
2 0 5
1 1 4
2 0 4
1 0 2
1 0 2
1 0 1
1 1 8
3 0 5
3 0 4
1 0 1
0 0 0
 antigen; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; M, male; SD,
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glomerulonephritis might be overlooked because the detection of
viral antigens or nucleic acids is only performed on the renal tissues
of patients who are seropositive for the viral antigen or antibody.
This study tested for HBV and HCV antigens in the fresh renal tissues
of patients who were determined to be negative for HBV and HCV
(mainly through serological tests). HBV and/or HCV antigens were
found in 18 out of 500 cases. Unexpectedly, the positive rate of HCV
antigen was almost identical to that of HBV antigens. In China, the
prevalence of HCV infection is lower, so testing for HCV is not
typically performed on patients with glomerulonephritis.25 How-
ever, this result indicates that occult HCV infection may be a severe
problem, and it should be a cause for concern. Though it is
regrettable that virus nucleic acids were not detected in this study
because the basic diagnosis must be assured ﬁrst and there was
insufﬁcient tissue for PCR, the detection of virus antigens in tissue
can also indicate that occult hepatitis virus infection might be
associated with glomerulonephritis by immune complex deposi-
tion. Additionally, the clinicopathological features of patients with
virus antigens in renal tissue are similar to those of patients with
HBV-associated glomerulonephritis.3
The results suggest that occult hepatitis virus infection might
also cause HBV- or HCV-associated glomerulonephritis. The virus
antigens should be detected by conventional means in renal tissue
of glomerulonephritis patients in order to determine the diagnosis.
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